Form 4 for CLX Clorox
Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-20 · accession 0001225208-22-010418 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-22 | 2022-09-20 | CLX | Grier Stacey | EVP - Chief Growth, Str Ofc | A - Grant | $141.30 | +2,264 | 6,716 | +51% | +$319.9K |
| D | 2022-09-22 | 2022-09-20 | CLX | Grier Stacey | EVP - Chief Growth, Str Ofc | A - Grant | $0.00 | +11.9K | 11.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-20 | A | A | 2,264 | $141.30 | 6,716 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-09-20 | A | A | 11,869 | $0.00 | 11,869 | D | $141.90 · 2023-10-05 to 2032-09-20 | 11,869 Common Stock | (F2) Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026. |